Browse diseases

…erapy in addition to high-dose inhaled corticosteroids (ICS) in severe asthma. Adherence to maintenance therapy is a determining factor in di…

…Introduction Severe asthma incurs a financial burden on both patients and societies. Howev…

…al.Conclusions The carbon footprints of biologic treatments for severe asthma vary widely, driven primarily by differences in dose and manufa…

…onclusion This study provides a previously unknown insight into severe asthma patient views on their preferred frequency of biologic administ…

… statistics were performed.Results A total of 145 patients with severe asthma initiated on Tezepelumab were included in the analysis. Baselin…

… objectives. The selection of performance outcomes measures for severe asthma clinical quality improvement from clinician and patient perspec…

…Introduction Severe asthma is characterised by inflammation and structural remodelling of …

…d non-response.Methods We conducted a retrospective analysis of severe asthma patients treated with biologics for 12 months (March 2014– 2025…

… study formed exploratory and validation cohorts of adults with severe asthma starting biologic treatment. The primary outcome was achievemen…

…amine or subcutaneous adrenaline as a second-line treatment for severe asthma.Methods We included only randomised controlled trials (RCTs) an…

…g pathway (SDP) was developed (see figure 1) and implemented in severe asthma patients stable on biologic therapy for >12 months in a pharmac…

…8 Figure 1Proportion of patients reporting a negative impact of severe asthma on different areas of lifeConclusions SA continues to place a s…